소염약침액이 Collagen II 유발 관절염 mouse의 TNF-α, IFN-γ 생성 및 비장세포 증식에 미치는 영향 = Inhibitory Effects of Soyeum Pharmacopuncture (SPP) on Rheumatoid Arthritis in Collagen II-induced Arthritis (CIA) Mice

다국어 초록 (Multilingual Abstract)

Objective : The aim is to examine the effect of Soyeum Pharmacopuncture (SPP) on collagen-induced arthritis (CIA) in DBA/1OlaHsd mice. Methods : To determine the effect of SPP on chronic IFNlammatory joint disease, we induced CIA in DBA/1OlaHsd mice by immunization with bovine type II collagen. Animals were treated with intraperitoneal injection doses of 2 mg/kg of SPP, beginning 3 days before the expected onset of disease symptoms. Inhibitory Effects of SPP were observed by serum levels of TNF-${\alpha}$, and IFN-${\gamma}$,,, or cell proliferation in the spleen cell culture and histological examination of knee joint. Results : In the CIA Mice, serum levels of TNF-${\alpha}$, and IFN-${\gamma}$,, production in the spleen cell culture were reduced. At the histopathological examination of knee joint, chondropathy of cartilage in the synovial joint in the SP group was repaired while compared with control group. Conclusion : These results suggest that the SPP may be effective for the prevention and treatment of rheumatoid arthritis disease.

참고문헌 (Reference)

• 1 조영주, "희첨이 炎症性 사이토카인 및 류마티스양 關節炎에 미치는 影響" 2003
• 2 서형식, "소염 약침액이 Staphylococcus aureus와 Staphylococcus epidermidis에 미치는 항균효과에 대한 실험적 연구" 대한약침학회 9 (9): 73-77, 2006
• 3 서형식, "소염 약침액, 황련해독탕, 황련이 Staphylococcus aureus에 미치는 항균효과에 대한 실험적 연구" 대한약침학회 9 (9): 87-92, 2006
• 4 "계혈등의 항염활성효과" 1999
• 5 김병수, "玄胡索. 赤芍藥. 紅花 混合藥鍼液이 關節炎 白鼠의 炎症과 肝에 미치는 影響" 2004
• 6 "et al. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature. 353" 858-861, 1991
• 7 "et al. Function of B cells expressing a human immunoglobulin M rhematoid factor autoantibody in transgenic mice. J Exp Med 177" 109-118, 1993
• 8 "Weinblatt ME. Toxicity of low dose methotrexate in rheumatoid arthritis. J Rheumatol 1985" 35-9,
• 9 "Therapeutic strategies for rheumatoid arthritis" 2 (2): 473-488, 2003
• 10 Tsuchiya S, "Tada K. Establishment and characterization of a human acute monocytic leukemia cell line" 171-1 176, 1980
• 11 Feldmann M, "Role of cytokines in rheumatoid arthritis" 14 : 397-440, 1996
• 12 Weinblatt ME, "Rheumatoid arthritis" 358 : 903-911, 2001
• 13 "Rheumatoid arthritis" 358 : 903-911, 2001
• 14 "Randomised placebo-controlled study of stopping secondline drugs in rheumatoid arthritis" 10 (10): 347-352, 1996
• 15 F.H. Chen, "Oligoglycosides, notoginsenosides-A, -B, -C, and -D, from the dried root of Panax notoginseng (Burk.)" 45 : 1039-1045, 1997
• 16 "Kipps TJ. New roles for rheumatoid factor. J Clin Invest 87" 379-383, 1991
• 17 Bradley, D. S, "HLA-DQB1 polymorphism determines incidence, onset, and severity of collagen-induced arthritis in transgenic mice: implications in human rheumatoid arthritis" 100 : 2227-2234, 1997
• 18 American college of Rheumatology Ad Hoc Committee on Clinical Guidelines, "Guidelines for monitoring drug therapy in rheumatoid arthritis" 39 : 723-731, 1996
• 19 "Evolving concepts of rheumatoid arthritis" 423 : 356-361, 2003
• 20 Kim DS, "Dammarane saponins from Panax ginseng" 40 (40): 1493-1497, 1995
• 21 "DMARDs in the treatment of rheumatoid arthritis: current agents and future developments" 54 : 243-249, 2000
• 22 "DMARD use in early rheumatoid arthritis. Lessons from observations in patients with established disease" 21 (21): S169-S173, 2003
• 23 "Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?" 19 : 163-196, 2001
• 24 Iwai H, "Amelioration of collagen-induced arthritis by blocade of inducible costimulator-B7 homologous protein costimulation" 169 : 4332-4339, 2002